U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313826) titled 'Treatment of Chronic Lower Back Pain With a Combination of Electrical Stimulation, LED, and Laser Therapy' on Dec. 30, 2025.

Brief Summary: This study will evaluate the impact of the Neurolumen medical device on chronic low back pain.

Study Start Date: May 01, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Low Back Pain

Intervention: DEVICE: Active Neurolumen

Neurolumen has been cleared by the FDA for the treatment of pain (FDA: 142025) and utilizes a combination of low-level lasers, Light-Emitting Diodes, and electrical stimulation over a 30-minute treatment period to target inflammation and circulation to the affected ar...